Samsung v. Oura Health: Galaxy Ring Patent Suit Dismissed on the Merits
Samsung and Samsung Electronics America filed five patent infringement claims against Oura Health Oy and Ouraring Inc. in the Northern District of California, targeting smart ring wearable technology. After 354 days, the court granted Oura’s motion to dismiss — entering judgment on the merits in favor of the defendants across all five asserted patents.
Samsung’s Galaxy Ring infringement suit ends in Oura’s favour at first instance
Samsung Electronics Co., Ltd. and Samsung Electronics America, Inc. filed suit on 30 May 2024 in the Northern District of California against Finnish smart ring maker Oura Health Oy and its US subsidiary Ouraring Inc. The complaint asserted five US patents — US10893833B2, US11868178B2, US11868179B2, US11599147B2, and US10842429B2 — all directed at wearable health-monitoring technology. The central dispute concerned whether Samsung’s Galaxy Ring infringed those asserted patents.
The case closed on 19 May 2025 when the court entered judgment in favour of the defendants following an order granting Oura’s motion to dismiss (ECF No. 57). Judgment on the merits at the motion-to-dismiss stage is procedurally significant: it indicates the court found Samsung’s complaint legally deficient on its face, not merely procedurally flawed, giving Oura a substantive adjudication rather than a provisional reprieve.
A resolution after just 354 days — at the motion-to-dismiss stage, before claim construction or summary judgment — suggests the court found a fundamental deficiency in Samsung’s pleading. The public record does not disclose the specific legal basis of the dismissal order (ECF No. 57), leaving open whether the ruling turned on patent eligibility under § 101, failure to plead direct or indirect infringement adequately, or another substantive ground. What remains unknown is whether Samsung intends to appeal.
Filing to Judgment on the merits for Defendant in 354 days
354 days from filing to dismissal — faster than the median N.D. Cal. patent case
Judgment on the merits for Oura: what the ruling means for both parties
Motion to dismiss granted — a merits ruling, not a procedural exit
A dismissal order granting a motion to dismiss that results in judgment on the merits is substantively distinct from a voluntary or procedural dismissal. Here, the court found Samsung’s complaint legally insufficient on its face across all five asserted patents. Such a ruling typically signals a fundamental defect — potentially patent-ineligible subject matter, inadequate pleading of infringement, or failure to identify a cognizable claim — rather than a curable procedural deficiency.
Merits adjudicationSamsung loses the opening round across all five patents
With judgment entered against Samsung on the merits, the plaintiffs face a meaningful barrier to re-litigating the same infringement theory in the same court. To continue pursuit, Samsung would need to appeal to the Federal Circuit or identify a materially distinct infringement theory. The outcome does not invalidate the five asserted patents — they remain in Samsung’s portfolio — but this court has now ruled that the complaint as pleaded did not support liability.
Patents survive; infringement claim failsOura secures a merits win without reaching claim construction
For Oura Health and Ouraring Inc., a judgment on the merits at the pleading stage is a strong result: the company avoids the cost and uncertainty of claim construction, discovery, and trial while securing a substantive court ruling. The decision strengthens Oura’s position in any parallel or future proceedings and may deter similar infringement assertions from Samsung on the same theory. Oura’s commercial Galaxy Ring roadmap faces reduced immediate legal disruption.
Oura: full merits dismissal securedSmart ring IP landscape: early dismissal signals patentability risk
The outcome suggests that smart ring wearable patent claims may face scrutiny at the pleading stage in N.D. California — a court that has historically applied rigorous § 101 analysis. Competitors and investors in the wearable health-monitoring sector should note that asserting broad portfolio patents against well-resourced defendants carries dismissal risk before claim construction. The case also highlights the value of robust motion-to-dismiss strategy for defendants facing large-plaintiff assertions.
Pleading-stage risk for wearable IPFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Samsung Group | Company | Consumer electronics and wearables group — holder of US10893833B2 and 4 further smart ring patentsSearch in Eureka ↗ |
| Co-Plaintiff | Samsung Electronics America, Inc. | Company | Search in Eureka ↗ |
| Defendant | Oura Health Oy | Individual | Finnish smart ring maker Oura Health Oy and US subsidiary Ouraring Inc., makers of the Oura RingSearch in Eureka ↗ |
| Co-Defendant | Ouraring, Inc. | Company | Search in Eureka ↗ |
| Plaintiff counsel | Bill Trac | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Cason Cole | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Gyuhyun Bae | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Marc J. Pensabene | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Mark Liang | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Ryan Ken Yagura | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff counsel | Sorin Gabriel Zaharia | Attorney | Counsel for Samsung GroupSearch in Eureka ↗ |
| Plaintiff law firm | O’melveney & Myers LLP | Law Firm | Representing Samsung GroupSearch in Eureka ↗ |
| Defendant counsel | Janine Alison Carlan | Attorney | Counsel for Oura Health OySearch in Eureka ↗ |
| Defendant counsel | Jasjit Vidwan | Attorney | Counsel for Oura Health OySearch in Eureka ↗ |
| Defendant counsel | Michael John Newton | Attorney | Counsel for Oura Health OySearch in Eureka ↗ |
| Defendant counsel | Taniel E. Anderson | Attorney | Counsel for Oura Health OySearch in Eureka ↗ |
| Defendant counsel | Yuri Mikulka | Attorney | Counsel for Oura Health OySearch in Eureka ↗ |
| Defendant law firm | Alston & Bird LLP | Law Firm | Representing Oura Health OySearch in Eureka ↗ |
| Defendant law firm | ArentFox Schiff LLP | Law Firm | Representing Oura Health OySearch in Eureka ↗ |
| Defendant law firm | Mayer Brown LLP | Law Firm | Representing Oura Health OySearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | California Northern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The judgment entry is terse but consequential: it expressly ties the outcome to ECF No. 57 — the order granting defendants’ motion to dismiss — and invokes FRCP 58 to formalise judgment in Oura’s favour on the merits. This framing confirms the disposition is not a voluntary withdrawal or procedural housekeeping; the court adjudicated the sufficiency of Samsung’s complaint and found it wanting. For Samsung, the FRCP 58 judgment creates a formal appellate trigger. For Oura, it provides a record-backed merits ruling that carries estoppel implications should Samsung attempt to relitigate the same infringement theory.
US10893833B2 and four co-asserted smart ring wearable patents
The five asserted patents — US10893833B2, US11868178B2, US11868179B2, US11599147B2, and US10842429B2 — collectively cover smart ring wearable technology including health and activity monitoring, biometric sensing, and associated data-processing methods. The patent families span application filings from US15/835573 through US18/323386, reflecting a portfolio built over multiple years as Samsung invested in ring-form-factor health devices. The technical domain sits at the intersection of miniaturised sensor hardware and software-driven health analytics.
Strategically, this five-patent portfolio represents Samsung’s attempt to assert first-mover or co-development rights over core smart ring functionality — precisely the space Oura occupies commercially. The outcome of this case does not affect the patents’ validity or their potential use against third parties, but it does signal that the claims as pleaded may not map cleanly to Oura’s specific implementation of the Galaxy Ring technology. Competitors building ring-form wearables should conduct freedom-to-operate analysis against this portfolio regardless of the litigation outcome.
Should your product team run an FTO against these five Samsung smart ring patents?
Any company developing or commercialising smart ring wearable devices — particularly those incorporating biometric sensors, continuous health monitoring, or ring-form-factor data processing — should treat this Samsung portfolio as a live enforcement risk. Despite losing this specific action against Oura, Samsung retains all five patents and the commercial motive to defend its Galaxy Ring market position. Medical wearable startups, consumer electronics OEMs, and health platform providers entering the smart ring segment face meaningful exposure.
PatSnap Eureka’s FTO Search Agent can map your product’s feature set against the independent claims of US10893833B2, US11868178B2, US11868179B2, US11599147B2, and US10842429B2 — identifying claim elements that may read on your technology and surfacing prior art that could support design-arounds or invalidity arguments. Eureka’s prosecution history analysis also flags any file-wrapper estoppels that narrow claim scope, giving your legal team a defensible FTO opinion faster than traditional manual review.
Run a freedom-to-operate analysis on US10893833B2 to assess your product’s exposure
Run FTO in Eureka →Similar smart ring and wearable health-tech patent cases in N.D. California
Cases involving wearable health-monitoring patents dismissed at the pleading stage in the Northern District of California, including smart ring and biometric sensor disputes.
What this case signals for the wearable health technology IP landscape
An early merits dismissal in a five-patent Galaxy Ring suit reshapes how both plaintiffs and defendants should approach smart ring IP strategy.
Defendants should prioritise motion-to-dismiss strategy in wearable patent suits
Oura’s success at the pleading stage — before claim construction — demonstrates that a well-crafted motion to dismiss can terminate even a multi-patent, large-plaintiff assertion. Companies facing wearable health-tech infringement complaints in N.D. California should invest early in identifying threshold legal deficiencies, including § 101 eligibility and pleading adequacy, before engaging in costly discovery.
Samsung’s five asserted patents remain live enforcement assets despite the loss
Judgment on the merits in this case is case-specific and does not invalidate US10893833B2 or the four co-asserted patents. Samsung retains the ability to assert these patents against other parties, in different courts, or on remand if it appeals. Portfolio holders watching this case should treat it as a pleading risk signal, not a validity determination.
Samsung v Oura — key questions answered
The court entered judgment on the merits in favour of defendants Oura Health Oy and Ouraring Inc. after granting their motion to dismiss (ECF No. 57). The case, filed 30 May 2024 in the Northern District of California, closed 19 May 2025 after 354 days. All five Samsung patents were dismissed without reaching claim construction.
Samsung asserted five US patents: US10893833B2, US11868178B2, US11868179B2, US11599147B2, and US10842429B2. These patents cover smart ring wearable technology including health monitoring, biometric sensing, and ring-form-factor data processing. The asserted product at issue was the Samsung Galaxy Ring.
When a court grants a motion to dismiss and enters judgment on the merits for the defendant, it means the court found the plaintiff’s complaint legally deficient on its face — not merely procedurally flawed. In patent cases, this frequently arises from inadequate pleading of infringement or patent-ineligible subject matter under § 101. Unlike a dismissal without prejudice, a merits judgment carries estoppel implications and creates a formal appellate record under FRCP 58.
Yes. Because judgment was formally entered under FRCP 58, Samsung has a clear appellate trigger to seek review by the United States Court of Appeals for the Federal Circuit, which has exclusive jurisdiction over patent case appeals. The public record as of the case closing date does not confirm whether Samsung has filed a notice of appeal. If it does, the Federal Circuit will review the motion-to-dismiss ruling, likely under a de novo standard.
No. A judgment on the merits at the motion-to-dismiss stage does not invalidate the asserted patents. Samsung’s US10893833B2, US11868178B2, US11868179B2, US11599147B2, and US10842429B2 remain in force and can be asserted against other parties. The ruling determined only that Samsung’s complaint as pleaded did not support an infringement claim against Oura in this action.
PatSnap Eureka searches patents and litigation data to answer instantly.